Select Equity Group, L.P. Bio Rad Laboratories, Inc. Transaction History
Select Equity Group, L.P.
- $22.1 Billion
- Q4 2024
A detailed history of Select Equity Group, L.P. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Select Equity Group, L.P. holds 460,658 shares of BIO stock, worth $117 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
460,658
Previous 708,452
34.98%
Holding current value
$117 Million
Previous $237 Million
36.16%
% of portfolio
0.69%
Previous 0.95%
Shares
10 transactions
Others Institutions Holding BIO
# of Institutions
478Shares Held
19.2MCall Options Held
15.7KPut Options Held
11.5K-
Vanguard Group Inc Valley Forge, PA1.92MShares$489 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$395 Million0.01% of portfolio
-
Wealthfront Advisers LLC1.04MShares$265 Million0.29% of portfolio
-
Veritas Asset Management LLP977KShares$249 Million3.36% of portfolio
-
Dimensional Fund Advisors LP Austin, TX746KShares$190 Million0.06% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.27B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...